Abstract
Neutrophil (PMN) infiltration of the intestinal mucosa is a hallmark of tissue injury associated with inflammatory bowel diseases (IBDs). The pathological effects of PMNs are largely attributed to the release of soluble mediators and reactive oxygen species (ROS). We identified what we believe is a new, ROS-independent mechanism whereby activated tissue-infiltrating PMNs release microparticles armed with proinflammatory microRNAs (miR-23a and miR-155). Using IBD clinical samples, and in vitro and in vivo injury models, we show that PMN-derived miR-23a and miR-155 promote accumulation of double-strand breaks (DSBs) by inducing lamin B1–dependent replication fork collapse and inhibition of homologous recombination (HR) by targeting HR-regulator RAD51. DSB accumulation in injured epithelium led to impaired colonic healing and genomic instability. Targeted inhibition of miR-23a and miR-155 in cultured intestinal epithelial cells and in acutely injured mucosa decreased the detrimental effects of PMNs and enhanced tissue healing responses, suggesting that this approach can be used in therapies aimed at resolution of inflammation, in wound healing, and potentially to prevent neoplasia.
Original language | English (US) |
---|---|
Pages (from-to) | 712-726 |
Number of pages | 15 |
Journal | Journal of Clinical Investigation |
Volume | 129 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1 2019 |
Funding
This work was supported by grants from the National Institutes of Health (DK101675), Digestive Health Foundation, Chicago, a Research Scholar Grant by the American Cancer Society (RSG-17-235-01-CSM), and by the Robert H. Lurie Comprehensive Cancer Center (Eisenberg Scholar grant). We thank the Northwestern University Center for Advanced Microscopy core (supported by a National Cancer Institute Cancer Center Support Grant P30 CA060553, awarded to the Robert H. Lurie Comprehensive Cancer Center) for help with the imaging experiments. The colonoids/ organoid work was supported by the Mayo Clinic Center for Cell Signaling in Gastroenterology (National Institute of Diabetes and Digestive and Kidney Diseases, P30DK084567) and Lisa Boardman (clinical core).
ASJC Scopus subject areas
- General Medicine